Opinion | Rampant trade tariffs are no cure for the US’ fentanyl crisis
The public health disaster results from the US’ painkiller culture. Meanwhile, tariff hikes are sparking serious concerns about a recession

It should be obvious to any discerning observer that this move is political manipulation intended to deflect attention away from the US’ domestic problems, a typical example of trade bullying and a serious provocation to the international economic and trade order.
Nevertheless, in line with the spirit of humanitarianism, in recent years, China has actively supported the US in addressing the fentanyl issue at its request.
As early as in 2019, China became the first country in the world to schedule fentanyl-related substances as a whole class of prohibited substances. In 2024, the US Department of State said in its International Narcotics Control Strategy Report: “Almost no fentanyl or fentanyl analogues have been detected directly entering the United States from the People’s Republic of China (PRC) since the PRC implemented controls over fentanyl-related substances as a class in 2019.”